Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

HPV as a model for the development of prophylactic and therapeutic cancer vaccines.

Samara RN, Khleif SN.

Curr Mol Med. 2009 Aug;9(6):766-73. Review.

PMID:
19689303
2.

Human papillomavirus vaccines for the prevention and treatment of cervical cancer.

Tomson TT, Roden RB, Wu TC.

Curr Opin Investig Drugs. 2004 Dec;5(12):1247-61. Review.

PMID:
15648945
3.

Perspectives for the development of human papillomavirus vaccines and immunotherapy.

Bermúdez-Humarán LG, Langella P.

Expert Rev Vaccines. 2010 Jan;9(1):35-44. doi: 10.1586/erv.09.145. Review.

PMID:
20021304
4.

Vaccines against human papillomavirus.

Lin YY, Alphs H, Hung CF, Roden RB, Wu TC.

Front Biosci. 2007 Jan 1;12:246-64. Review.

PMID:
17127297
5.

Human papillomavirus vaccines for the treatment of cervical cancer.

Sin JI.

Expert Rev Vaccines. 2006 Dec;5(6):783-92. Review.

PMID:
17184217
6.

An overview of human papillomaviruses and current vaccine strategies.

Gnanamony M, Peedicayil A, Abraham P.

Indian J Med Microbiol. 2007 Jan;25(1):10-7. Review.

7.

Papillomavirus vaccines.

Duggan-Keen MF, Brown MD, Stacey SN, Stern PL.

Front Biosci. 1998 Dec 1;3:D1192-208. Review.

PMID:
9835649
8.

[Prophylactic and therapeutic vaccination against human papillomavirus].

Brun JL, Riethmuller D.

J Gynecol Obstet Biol Reprod (Paris). 2007 Nov;36(7):631-41. Epub 2007 Sep 5. Review. French.

9.

Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.

Bhat P, Mattarollo SR, Gosmann C, Frazer IH, Leggatt GR.

Immunol Rev. 2011 Jan;239(1):85-98. doi: 10.1111/j.1600-065X.2010.00966.x. Review.

PMID:
21198666
10.
11.

Human papillomavirus infection: an old disease, a new vaccine.

Giles M, Garland S.

Aust N Z J Obstet Gynaecol. 2006 Jun;46(3):180-5. Review.

PMID:
16704468
12.

[Advances in human papillomavirus therapeutic vaccine].

Liu B, Zhao QZ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):685-90. Review. Chinese.

13.

[Prophylactic and therapeutic vaccine therapy in papillomavirus infections].

Vinatier D, Cosson M, Dufour P.

Gynecol Obstet Fertil. 2000 May;28(5):370-84. Review. French.

PMID:
10893881
14.

Papillomavirus virus-like particles as anticancer vaccines.

Da Silva DM, Velders MP, Rudolf MP, Schiller JT, Kast WM.

Curr Opin Mol Ther. 1999 Feb;1(1):82-8. Review.

PMID:
11249689
15.

Global stability of equilibria in a two-sex HPV vaccination model.

Elbasha EH.

Bull Math Biol. 2008 Apr;70(3):894-909. Epub 2007 Nov 13.

PMID:
17999117
16.

Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines.

Einstein MH.

Cancer Immunol Immunother. 2008 Apr;57(4):443-51. Epub 2007 Dec 22. Review.

PMID:
18157723
17.
18.

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

Stanley M, Lowy DR, Frazer I.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. Epub 2006 Jun 23. Review.

PMID:
16949996
19.

HPV protein/peptide vaccines: from animal models to clinical trials.

Fausch SC, Da Silva DM, Eiben GL, Le Poole IC, Kast WM.

Front Biosci. 2003 Jan 1;8:s81-91. Review.

PMID:
12456298
20.

The therapeutic vaccine: is it feasible?

Gissmann L, Nieto K.

Arch Med Res. 2009 Aug;40(6):493-8. doi: 10.1016/j.arcmed.2009.07.003. Epub 2009 Sep 5. Review.

PMID:
19853190

Supplemental Content

Support Center